This Week in Nature

In Nature this week, researchers from the University of Bonn and the University of California, Los Angeles, describe the use of a genetically engineered mouse to how melanomas become resistant to treatment. Adoptive cell therapies, which fight tumors with cytotoxic T cells, are often initially effective in treating melanoma, but patients frequently relapse.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."